Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Dekkers, JF"'
Autor:
Dekkers, JF, van Mourik, P, Vonk, AM, Kruisselbrink, E, Berkers, G, de Winter-de Groot, KM, Janssens, Hettie, Bronsveld, I, van der Ent, CK, de Jonge, Hugo, Beekman, JM
Publikováno v:
Journal of Cystic Fibrosis, 15(5), 568-578. Elsevier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::3ffcc8806539cd161097a32d27c9dfcd
https://pure.eur.nl/en/publications/2ca14c69-8a74-46d1-8c6c-a4d5e41b433b
https://pure.eur.nl/en/publications/2ca14c69-8a74-46d1-8c6c-a4d5e41b433b
Autor:
Alieva M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. malieva@iib.uam.es.; Instituto de Investigaciones Biomédicas Sols-Morreale (IIBM), CSIC-UAM, Madrid, Spain. malieva@iib.uam.es., Barrera Román M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., de Blank S; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Petcu D; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Zeeman AL; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Dautzenberg NMM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Cornel AM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Center for Translational Immunology, University Medical Centre (UMC) Utrecht, Utrecht, the Netherlands., van de Ven C; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Pieters R; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., den Boer ML; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Nierkens S; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Center for Translational Immunology, University Medical Centre (UMC) Utrecht, Utrecht, the Netherlands., Calkoen FGJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Clevers H; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, Utrecht, the Netherlands.; Pharma, Research and Early Development (pRED), F. Hoffmann-La Roche Ltd, Basel, Switzerland., Kuball J; Center for Translational Immunology, University Medical Centre (UMC) Utrecht, Utrecht, the Netherlands.; Department of Hematology, UMC Utrecht, Utrecht University, Utrecht, the Netherlands., Sebestyén Z; Center for Translational Immunology, University Medical Centre (UMC) Utrecht, Utrecht, the Netherlands., Wehrens EJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Dekkers JF; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Rios AC; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. a.c.rios@prinsesmaximacentrum.nl.; Oncode Institute, Utrecht, the Netherlands. a.c.rios@prinsesmaximacentrum.nl.
Publikováno v:
Nature protocols [Nat Protoc] 2024 Jul; Vol. 19 (7), pp. 2052-2084. Date of Electronic Publication: 2024 Mar 19.
Autor:
Jeremiasse B; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., van Ineveld RL; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Bok V; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Kleinnijenhuis M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., de Blank S; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Alieva M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Instituto de Investigaciones Biomedicas Sols-Morreale (IIBM), CSIC-UAM, Madrid, Spain., Johnson HR; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., van Vliet EJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Zeeman AL; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Wellens LM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Llibre-Palomar G; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Barrera Román M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Di Maggio A; Pharmaceutics, Department of Pharmaceutical Sciences, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584 CG, Utrecht, The Netherlands.; Cell Biology, Neurobiology and Biophysics, Department of Biology, Science Faculty, Utrecht University, 3584 CH, Utrecht, The Netherlands., Dekkers JF; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Oliveira S; Pharmaceutics, Department of Pharmaceutical Sciences, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584 CG, Utrecht, The Netherlands.; Cell Biology, Neurobiology and Biophysics, Department of Biology, Science Faculty, Utrecht University, 3584 CH, Utrecht, The Netherlands., Vahrmeijer AL; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands., Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Wijnen MH; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van der Steeg AF; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Wehrens EJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Rios AC; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. a.c.rios@prinsesmaximacentrum.nl.; Oncode Institute, Utrecht, The Netherlands. a.c.rios@prinsesmaximacentrum.nl.
Publikováno v:
EMBO molecular medicine [EMBO Mol Med] 2024 Jul; Vol. 16 (7), pp. 1495-1514. Date of Electronic Publication: 2024 Jun 03.
Autor:
Vennin C; Division of Molecular Pathology, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066CX Amsterdam, the Netherlands; Oncode Institute, Amsterdam, the Netherlands., Cattaneo CM; Oncode Institute, Amsterdam, the Netherlands; Department of Molecular Oncology and Immunology, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066CX Amsterdam, the Netherlands., Bosch L; Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081HV Amsterdam, the Netherlands., Vegna S; Oncode Institute, Amsterdam, the Netherlands; Division of Tumor Biology and Immunology, Oncode Institute, the Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands., Ma X; Oncode Institute, Amsterdam, the Netherlands; Department of Molecular Oncology and Immunology, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066CX Amsterdam, the Netherlands., Damstra HGJ; Cell Biology, Neurobiology and Biophysics, Department of Biology, Faculty of Science, Utrecht University, 3584CT Utrecht, the Netherlands., Martinovic M; Division of Gene Regulation, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066CX Amsterdam, the Netherlands., Tsouri E; Oncode Institute, Amsterdam, the Netherlands; Division of Tumor Biology and Immunology, Oncode Institute, the Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands., Ilic M; Oncode Institute, Amsterdam, the Netherlands; Division of Cell Biology, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066CX Amsterdam, the Netherlands., Azarang L; Biostatistics Centre & Department of Psychosocial Research and Epidemiology, the Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands., van Weering JRT; Department of Human Genetics, Center for Neurogenomics and Cognitive Research, Amsterdam UMC, 1105AZ Amsterdam, the Netherlands., Pulver E; Division of Molecular Pathology, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066CX Amsterdam, the Netherlands; Oncode Institute, Amsterdam, the Netherlands., Zeeman AL; Oncode Institute, Amsterdam, the Netherlands; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Centre (UMC), 3584CT Utrecht, the Netherlands; Princess Maxima Center for Pediatric Oncology, 3584CT Utrecht, the Netherlands., Schelfhorst T; Division of Molecular Pathology, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066CX Amsterdam, the Netherlands; Oncode Institute, Amsterdam, the Netherlands., Lohuis JO; Division of Molecular Pathology, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066CX Amsterdam, the Netherlands; Oncode Institute, Amsterdam, the Netherlands., Rios AC; Oncode Institute, Amsterdam, the Netherlands; Princess Maxima Center for Pediatric Oncology, 3584CT Utrecht, the Netherlands., Dekkers JF; Oncode Institute, Amsterdam, the Netherlands; Princess Maxima Center for Pediatric Oncology, 3584CT Utrecht, the Netherlands., Akkari L; Oncode Institute, Amsterdam, the Netherlands; Division of Tumor Biology and Immunology, Oncode Institute, the Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands., Menezes R; Biostatistics Centre & Department of Psychosocial Research and Epidemiology, the Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands., Medema R; Oncode Institute, Amsterdam, the Netherlands; Division of Cell Biology, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066CX Amsterdam, the Netherlands., Baglio SR; Department of Pathology, Cancer Center Amsterdam, Amsterdam University Medical Center, Amsterdam, the Netherlands., Akhmanova A; Cell Biology, Neurobiology and Biophysics, Department of Biology, Faculty of Science, Utrecht University, 3584CT Utrecht, the Netherlands., Linn SC; Divisions of Molecular Pathology and of Medical Oncology, the Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands; Department of Pathology, University Medical Center, 1081HV Utrecht, the Netherlands., Lemeer S; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584CT Utrecht, the Netherlands; Netherlands Proteomics Center, 3584CT Utrecht, the Netherlands., Pegtel DM; Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081HV Amsterdam, the Netherlands., Voest EE; Oncode Institute, Amsterdam, the Netherlands; Department of Molecular Oncology and Immunology, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066CX Amsterdam, the Netherlands., van Rheenen J; Division of Molecular Pathology, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066CX Amsterdam, the Netherlands; Oncode Institute, Amsterdam, the Netherlands. Electronic address: j.v.rheenen@nki.nl.
Publikováno v:
Cancer cell [Cancer Cell] 2023 Jun 12; Vol. 41 (6), pp. 1170-1185.e12.
Autor:
Dekkers JF; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Utrecht, the Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Alieva M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Cleven A; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Keramati F; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Wezenaar AKL; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., van Vliet EJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Puschhof J; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Microbiome and Cancer Division, German Cancer Research Center, Heidelberg, Germany., Brazda P; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Johanna I; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Meringa AD; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Rebel HG; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Buchholz MB; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Barrera Román M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Zeeman AL; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., de Blank S; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Fasci D; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Geurts MH; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Cornel AM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Driehuis E; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Millen R; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Straetemans T; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; Department of Hematology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Nicolasen MJT; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Aarts-Riemens T; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Ariese HCR; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Johnson HR; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., van Ineveld RL; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Karaiskaki F; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Kopper O; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Bar-Ephraim YE; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Kretzschmar K; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Mildred Scheel Early Career Center for Cancer Research Würzburg, University Hospital Würzburg, MSNZ/IZKF, Wurzburg, Germany., Eggermont AMM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; University Medical Center Utrecht, Utrecht, the Netherlands.; Comprehensive Cancer Center München, Munich, Germany., Nierkens S; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Wehrens EJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Stunnenberg HG; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Clevers H; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Utrecht, the Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Pharma, Research and Early Development, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Kuball J; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; Department of Hematology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Sebestyen Z; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Rios AC; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. a.c.rios@prinsesmaximacentrum.nl.; Oncode Institute, Utrecht, the Netherlands. a.c.rios@prinsesmaximacentrum.nl.
Publikováno v:
Nature biotechnology [Nat Biotechnol] 2023 Jan; Vol. 41 (1), pp. 60-69. Date of Electronic Publication: 2022 Jul 25.
Autor:
Heitink L; ACRF Cancer Biology and Stem Cells Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, Australia., Whittle JR; ACRF Cancer Biology and Stem Cells Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, Australia.; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia., Vaillant F; ACRF Cancer Biology and Stem Cells Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, Australia., Capaldo BD; ACRF Cancer Biology and Stem Cells Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, Australia., Dekkers JF; ACRF Cancer Biology and Stem Cells Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Dawson CA; ACRF Cancer Biology and Stem Cells Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, Australia.; Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia., Milevskiy MJG; ACRF Cancer Biology and Stem Cells Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, Australia., Surgenor E; ACRF Cancer Biology and Stem Cells Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia., Tsai M; ACRF Cancer Biology and Stem Cells Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia., Chen HR; ACRF Cancer Biology and Stem Cells Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia., Christie M; Personalised Oncology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.; Department of Pathology, The Royal Melbourne Hospital, Parkville, Australia., Chen Y; Department of Medical Biology, The University of Melbourne, Parkville, Australia.; Bioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia., Smyth GK; Bioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.; School of Mathematics and Statistics, The University of Melbourne, Parkville, Australia., Herold MJ; Department of Medical Biology, The University of Melbourne, Parkville, Australia.; Blood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia., Strasser A; Department of Medical Biology, The University of Melbourne, Parkville, Australia.; Blood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia., Lindeman GJ; ACRF Cancer Biology and Stem Cells Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, Australia.; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia., Visvader JE; ACRF Cancer Biology and Stem Cells Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, Australia.
Publikováno v:
Molecular oncology [Mol Oncol] 2022 Mar; Vol. 16 (5), pp. 1119-1131. Date of Electronic Publication: 2022 Jan 26.
Autor:
Low JT; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia., Ho GY; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia.; School of Clinical Sciences, Monash University, Clayton, VIC, Australia., Scott M; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia.; Translational Research Institute Australia, Woolloongabba, QLD, Australia., Tan CW; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia., Whitehead L; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia., Barber K; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia., Yip HYK; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia.; Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC, Australia., Dekkers JF; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Princess Máxima Center for Pediatric Oncology, Utrecht, CT, The Netherlands.; Cancer Genomics Netherlands, Oncode Institute, Utrecht, CG, The Netherlands., Hirokawa Y; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia., Silke J; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia., Burgess AW; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia.; Department of Surgery, The University of Melbourne, Parkville, VIC, Australia., Strasser A; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia., Putoczki TL; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia.; Department of Surgery, The University of Melbourne, Parkville, VIC, Australia., O'Reilly LA; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia. oreilly@wehi.edu.au.; Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia. oreilly@wehi.edu.au.
Publikováno v:
Cell death & disease [Cell Death Dis] 2021 Nov 17; Vol. 12 (12), pp. 1091. Date of Electronic Publication: 2021 Nov 17.
Autor:
van Ineveld RL; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Cancer Genomics Netherlands, Oncode Institute, Utrecht, the Netherlands., Kleinnijenhuis M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Cancer Genomics Netherlands, Oncode Institute, Utrecht, the Netherlands., Alieva M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Cancer Genomics Netherlands, Oncode Institute, Utrecht, the Netherlands., de Blank S; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Cancer Genomics Netherlands, Oncode Institute, Utrecht, the Netherlands., Barrera Roman M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Cancer Genomics Netherlands, Oncode Institute, Utrecht, the Netherlands., van Vliet EJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Cancer Genomics Netherlands, Oncode Institute, Utrecht, the Netherlands., Martínez Mir C; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Cancer Genomics Netherlands, Oncode Institute, Utrecht, the Netherlands., Johnson HR; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Cancer Genomics Netherlands, Oncode Institute, Utrecht, the Netherlands., Bos FL; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Cancer Genomics Netherlands, Oncode Institute, Utrecht, the Netherlands., Heukers R; QVQ Holding BV, Utrecht, the Netherlands., Chuva de Sousa Lopes SM; Department of Anatomy and Embryology, Leiden University Medical Center, Leiden, the Netherlands., Drost J; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Cancer Genomics Netherlands, Oncode Institute, Utrecht, the Netherlands., Dekkers JF; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Cancer Genomics Netherlands, Oncode Institute, Utrecht, the Netherlands., Wehrens EJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Cancer Genomics Netherlands, Oncode Institute, Utrecht, the Netherlands., Rios AC; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. a.c.rios@prinsesmaximacentrum.nl.; Cancer Genomics Netherlands, Oncode Institute, Utrecht, the Netherlands. a.c.rios@prinsesmaximacentrum.nl.
Publikováno v:
Nature biotechnology [Nat Biotechnol] 2021 Oct; Vol. 39 (10), pp. 1239-1245. Date of Electronic Publication: 2021 Jun 03.
Autor:
Dekkers JF; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Centre (UMC), Utrecht, the Netherlands. j.f.dekkers@prinsesmaximacentrum.nl.; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. j.f.dekkers@prinsesmaximacentrum.nl.; Oncode Institute, Utrecht, the Netherlands. j.f.dekkers@prinsesmaximacentrum.nl., van Vliet EJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Sachs N; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Centre (UMC), Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Vertex Pharmaceuticals Inc, San Diego, CA, USA., Rosenbluth JM; Department of Cell Biology, Harvard Medical School, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Kopper O; NewStem, Silberman Institute for Life Sciences, Givat Ram, Jerusalem, Israel., Rebel HG; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Wehrens EJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Piani C; Foundation Hubrecht Organoid Technology (HUB), Utrecht, the Netherlands., Visvader JE; Cancer Biology and Stem Cells Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia., Verissimo CS; Foundation Hubrecht Organoid Technology (HUB), Utrecht, the Netherlands., Boj SF; Foundation Hubrecht Organoid Technology (HUB), Utrecht, the Netherlands., Brugge JS; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Clevers H; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Centre (UMC), Utrecht, the Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Rios AC; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.
Publikováno v:
Nature protocols [Nat Protoc] 2021 Apr; Vol. 16 (4), pp. 1936-1965. Date of Electronic Publication: 2021 Mar 10.
Autor:
Wellens LM; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.; Oncode Institute, Hubrecht Institute - KNAW, Utrecht, The Netherlands.; Cancer Genomics Center, Utrecht, The Netherlands., Deken MM; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands., Sier CFM; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands., Johnson HR; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.; Oncode Institute, Hubrecht Institute - KNAW, Utrecht, The Netherlands.; Cancer Genomics Center, Utrecht, The Netherlands., de la Jara Ortiz F; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands., Bhairosingh SS; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands., Houvast RD; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands., Kholosy WM; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands., Baart VM; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands., Pieters AMMJ; Department of Surgery, Maasstad Hospital, Rotterdam, The Netherlands., de Krijger RR; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands., Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands., Wehrens EJ; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.; Oncode Institute, Hubrecht Institute - KNAW, Utrecht, The Netherlands.; Cancer Genomics Center, Utrecht, The Netherlands., Dekkers JF; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.; Oncode Institute, Hubrecht Institute - KNAW, Utrecht, The Netherlands.; Cancer Genomics Center, Utrecht, The Netherlands., Wijnen MHWA; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands., Vahrmeijer AL; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands., Rios AC; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands. a.c.rios@prinsesmaximacentrum.nl.; Oncode Institute, Hubrecht Institute - KNAW, Utrecht, The Netherlands. a.c.rios@prinsesmaximacentrum.nl.; Cancer Genomics Center, Utrecht, The Netherlands. a.c.rios@prinsesmaximacentrum.nl.
Publikováno v:
Scientific reports [Sci Rep] 2020 Oct 19; Vol. 10 (1), pp. 17667. Date of Electronic Publication: 2020 Oct 19.